In the LPS-induced model of SAKI, it has been demonstrated that the suppression of abnormal immune responses through inhibition of the TLR4/NF-κB pathway might prevent AKI and improve the clinical outcome of sepsis. This evidence concerns the gene TLR4 and Sepsis.